Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Costs-proceeds calculation for radiotherapy; comment]

H J Thiel1, W A Oechsler, B Kastura

  • 1Institut für Strahlentherapie, Klinikum Bamberg.

Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Tick-borne encephalitis (TBE) with special emphasis on infection in horses].

DTW. Deutsche tierarztliche Wochenschrift·2006
Same author

[Noroviruses and sapoviruses in man and farm animals].

DTW. Deutsche tierarztliche Wochenschrift·2004
Same author

[Vaccination against foot and mouth disease: current state and perspectives].

DTW. Deutsche tierarztliche Wochenschrift·2002
Same author

[Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2001
Same author

Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma.

Journal of glaucoma·2001
Same author

A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus.

Journal of virology·2001

Modern radiotherapy is not cost-effective for 11 tumor entities, with significant underfunding evident, especially when including facility and investment costs. Reforms are urgently needed for accurate service payment and description in radiotherapy.

Area of Science:

  • Oncology
  • Health Economics
  • Radiotherapy

Background:

  • The Health Care Structure Bill and Federal Health Care Tariff Regulation introduced new challenges for hospital management, including internal budgeting.
  • The study addresses the impending establishment of care-related lump sums (Fallpauschalen) and special allowances for radiation therapy (Sonderentgelte).
  • A need was identified to assess the service-cost ratio for various tumor entities under new healthcare regulations.

Purpose of the Study:

  • To determine the service-cost ratio for 11 tumor entities in outpatient radiotherapy.
  • To compare calculated costs with actual proceeds from health insurance reimbursements.
  • To evaluate the economic viability of modern radiotherapy under current German healthcare regulations.

Main Methods:

Related Experiment Videos

  • Analysis included 11 tumor entities: Glioblastoma multiforme, head and neck squamous cell carcinoma, lung cancer, esophageal cancer, breast cancer, rectal and prostate cancer, anal canal and uterine cervix cancer, Hodgkin's disease, and bone metastases.
  • Treatment costs were calculated based on process evaluation, dividing the complex treatment regime into distinct steps.
  • Proceeds were calculated according to EBM (general health insurance) and GOA (private care insurance) regulations.

Main Results:

  • Under EBM standards, only ENT tumors, anal canal cancer, and bone metastases showed a profit margin when excluding facility and investment costs. All others incurred losses.
  • Including facility and investment costs, only bone metastases remained profitable; all other tumor entities resulted in significant financial losses.
  • Under GOA standards, all tumor entities showed a loss, with median losses ranging from -44% to -56% when including facility and investment costs.

Conclusions:

  • Modern standard radiotherapy is not cost-effective for the reviewed tumor entities, indicating considerable under-funding.
  • The cost-proceeds ratio is particularly unsatisfactory under GOA calculations, which are deemed obsolete for current radiotherapy standards.
  • Urgent reform of service description and payment is necessary to meet the standards of modern radiotherapy.